Marcos Almeida Matos1, André Prado1, Gustavo Schenkel1, Rosa Barreto2, Angelina Xavier Acosta2. 1. Bahia School of Medicine and Public Health , Santa Casa de Misericórdia da Bahia; Hospital Santa Isabel - Salvador, BA, Brazil. 2. University Hospital Professor Edgar Santos; Faculdade de Medicina da Universidade Federal da Bahia - Salvador, BA, Brazil.
Abstract
OBJECTIVE: The aim of this study is to evaluate energy expenditure in gait by mucopolysaccharidosis affected patients by means of a simple and adequate to the clinical environment methodology. METHODS: A cross-sectional study was carried out comparing energy expenditure during gait in 19 patients suffering from mucopolysaccharidosis (MPS Group) with 19 asymptomatic control individuals (Control Group). Energy expenditure was measured in calories (cal) using a Polar telemetric watch (model FT7) during a 50 meter walk. Variables such as age, weight, height, body mass index (BMI), initial hart rate, final hart rate, and walking time, were recorded. RESULTS: MPS Group showed a mean energy expenditure during gait of 2.84 cal (±1,01), versus 1.42 cal (±0,51), 100% higher than the Control Group; MPS also presented increased initial hart rate (22% higher), final hart rate (13% higher) and walking time (13% higher). CONCLUSIONS: Energy expenditure during gait in MPS patients was two times higher than control individuals; the methodology used showed to be a promising alternative, also adequate to the standard clinical environment. Level of Evidence III, Cross-sectional Comparative Study.
OBJECTIVE: The aim of this study is to evaluate energy expenditure in gait by mucopolysaccharidosis affected patients by means of a simple and adequate to the clinical environment methodology. METHODS: A cross-sectional study was carried out comparing energy expenditure during gait in 19 patients suffering from mucopolysaccharidosis (MPS Group) with 19 asymptomatic control individuals (Control Group). Energy expenditure was measured in calories (cal) using a Polar telemetric watch (model FT7) during a 50 meter walk. Variables such as age, weight, height, body mass index (BMI), initial hart rate, final hart rate, and walking time, were recorded. RESULTS:MPS Group showed a mean energy expenditure during gait of 2.84 cal (±1,01), versus 1.42 cal (±0,51), 100% higher than the Control Group; MPS also presented increased initial hart rate (22% higher), final hart rate (13% higher) and walking time (13% higher). CONCLUSIONS: Energy expenditure during gait in MPSpatients was two times higher than control individuals; the methodology used showed to be a promising alternative, also adequate to the standard clinical environment. Level of Evidence III, Cross-sectional Comparative Study.
Entities:
Keywords:
Evaluation; Gait; Mucopolysaccharidosis I
Authors: R Boyd; S Fatone; J Rodda; C Olesch; R Starr; E Cullis; D Gallagher; J B Carlin; G R Nattrass; K Graham Journal: Dev Med Child Neurol Date: 1999-10 Impact factor: 5.449
Authors: Paul Harmatz; David Ketteridge; Roberto Giugliani; Natalie Guffon; Elisa Leão Teles; M Clara Sá Miranda; Zi-Fan Yu; Stuart J Swiedler; John J Hopwood Journal: Pediatrics Date: 2005-06 Impact factor: 7.124
Authors: Inácio Teixeira Cunha; Peter A C Lim; Helene Henson; Trilok Monga; Huma Qureshy; Elizabeth J Protas Journal: Am J Phys Med Rehabil Date: 2002-11 Impact factor: 2.159
Authors: J Edmond Wraith; Maurizio Scarpa; Michael Beck; Olaf A Bodamer; Linda De Meirleir; Nathalie Guffon; Allan Meldgaard Lund; Gunilla Malm; Ans T Van der Ploeg; Jiri Zeman Journal: Eur J Pediatr Date: 2007-11-23 Impact factor: 3.183